RECURRENT PLASMA CELL MYELOMA
Clinical trials for RECURRENT PLASMA CELL MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PLASMA CELL MYELOMA trials appear
Sign up with your email to follow new studies for RECURRENT PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radiation 'Smart Bomb' targets Hard-to-Treat myeloma
Disease control Recruiting nowThis early-stage trial tests a new treatment for multiple myeloma that has come back or stopped responding to standard therapies. The treatment combines a cancer-targeting antibody (daratumumab) with a radioactive payload to deliver radiation directly to cancer cells. The study a…
Matched conditions: RECURRENT PLASMA CELL MYELOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 05:24 UTC
-
New hope for tough myeloma: Three-Drug combo trial launches
Disease control Recruiting nowThis study tests whether adding leflunomide to two standard drugs (pomalidomide and dexamethasone) can better control multiple myeloma that has come back or is resistant to treatment. About 29 adults with this type of blood cancer will receive the three-drug combination. The goal…
Matched conditions: RECURRENT PLASMA CELL MYELOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
Virus-Based therapy targets Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-phase trial tests a genetically modified virus (VSV-IFNβ-NIS) alone or with chemotherapy and immunotherapy drugs in people with blood cancers like multiple myeloma, acute myeloid leukemia, and lymphomas that have returned or not responded to treatment. The virus is des…
Matched conditions: RECURRENT PLASMA CELL MYELOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Engineered immune cells take aim at Hard-to-Treat multiple myeloma
Disease control Recruiting nowThis early-phase study tests a new treatment for adults with a type of blood cancer called multiple myeloma that has returned or stopped responding to standard therapies. The treatment involves taking a patient's own immune cells, modifying them in a lab to recognize and attack m…
Matched conditions: RECURRENT PLASMA CELL MYELOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Simple lifestyle changes and a common heart drug may improve quality of life for myeloma patients
Symptom relief Recruiting nowThis study looks at whether non-chemo approaches like physical activity, intermittent fasting, or adding a beta-blocker (propranolol) can improve immune function and quality of life in people with multiple myeloma or related blood disorders. About 175 adults with smoldering or ac…
Matched conditions: RECURRENT PLASMA CELL MYELOMA
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated May 22, 2026 13:52 UTC